Related Experiment Video
Updated: Aug 7, 2026
09:33
Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Amyloid and Alzheimer's disease--cause or effect?
1Department of Neurology, Harvard Medical School, Boston, MA.
Neurobiology of Aging
|September 1, 1989
Summary
Understanding Alzheimer's disease pathogenesis requires studying amyloid deposition. Research into amyloid precursor protein processing and amyloid's effects on neurons may clarify its role in Alzheimer's disease.
Area of Science:
- Neuroscience
- Pathology
- Biochemistry
Background:
- Alzheimer's disease (AD) pathogenesis is not fully understood.
- Amyloid deposition is a known feature of AD but its exact role remains unclear.
- Understanding normal amyloid precursor protein (APP) processing is key to identifying AD-related defects.
Purpose of the Study:
- To explore the link between APP processing and amyloid deposition in Alzheimer's disease.
- To investigate the neurobiological effects of amyloid in the central nervous system (CNS).
- To clarify the role of amyloid in the disease mechanisms of Alzheimer's disease.
Main Methods:
- Review of current literature on APP posttranslational processing.
- Analysis of recent findings on the biological and pathological effects of amyloid.
- Synthesis of knowledge regarding amyloid's role in CNS neuronal function and dysfunction.
Main Results:
- Advances in understanding normal APP processing may illuminate defects leading to amyloid deposition in AD.
- Recent insights reveal the biological and pathological impacts of amyloid on CNS neurons.
- The role of amyloid in AD pathogenesis is becoming clearer through these investigations.
Conclusions:
- A deeper understanding of APP processing and amyloid's neuronal effects is crucial for developing rational therapeutic strategies for Alzheimer's disease.
- Elucidating the precise mechanisms of amyloid deposition and its consequences is essential for future AD treatments.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...